Brampton's mayor says Ontario should change its Mental Health Act to allow forcible treatment in extreme addictions and ...

Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s.Scientists have created a drug that ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Scientists from Harvard Medical School are using artificial intelligence (AI) to solve the problem of finding treatments for rare and neglected diseases. They have developed a new method, called ...

Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development.

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...